Healthcare
Live Price
Offline$78.98
+0.57% today
1Y Change
+59.23%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
PTC Therapeutics, Inc. (PTCT) is a Healthcare stock with a market cap of $5.40B and listed on NASDAQ. The stock last traded around $78.98 and up 59.2% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +114.5%, EPS growth of +281.4%, a dividend yield of 0.0%. What stands out right now is revenue +114.5%, EPS +281.4%, free cash flow +486.0% with operating margin 49.5% and ROIC 37.4%. Valuation is more restrained than many high-expectation growth names at P/E 7.7 and price/sales 3.1. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines PTCT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PTCT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PTCT Max Drawdown
-27.17%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PTCT and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.